中國優通(06168.HK):仲裁委判令中國移動通信河北公司償還1.26億元
格隆匯4月29日丨中國優通(06168.HK)發佈公告,繼公司刊發日期為2020年3月31日的公告後,並無向石家莊仲裁委員會及其他仲裁委員會呈交針對中國移動通信河北公司的經修訂申請。於本公告日期,河北昌通已申請就針對中國移動通信河北公司的所有仲裁償還總額約人民幣3.25億元。
於本公告日期,石家莊仲裁委員會及其他仲裁委員會已判令中國移動通信河北公司就進行中的仲裁償還總額約人民幣1.26億元(包括服務費、河北昌通支付的按金及中國移動通信河北公司應付的違約金)。餘下未裁決服務費金額亦須待石家莊仲裁委員會及其他仲裁委員會未來裁決後方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.